Dose-Response: An International Journal
Volume 8
Issue 2 Special Issue on Hormesis and RadiationInduced Cancer

Article 4

6-2010

THE HEALTHY WORKER EFFECT AND
NUCLEAR INDUSTRY WORKERS
Krzysztof W Fornalski
The Andrzej Sołtan Institute for Nuclear Studies, Otwock-S´wierk, Poland

Ludwik Dobrzyn´ski
The Andrzej Sołtan Institute for Nuclear Studies, Otwock-S´wierk, Poland and University of Białystok, Lipowa,Białystok,
Poland

Follow this and additional works at: https://scholarworks.umass.edu/dose_response
Recommended Citation
Fornalski, Krzysztof W and Dobrzyn´ski, Ludwik (2010) "THE HEALTHY WORKER EFFECT AND NUCLEAR INDUSTRY
WORKERS," Dose-Response: An International Journal: Vol. 8 : Iss. 2 , Article 4.
Available at: https://scholarworks.umass.edu/dose_response/vol8/iss2/4

This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.

Fornalski and Dobrzyn´ski: Healthy worker effect

Dose-Response, 8:125–147, 2010
Formerly Nonlinearity in Biology, Toxicology, and Medicine
Copyright © 2010 University of Massachusetts
ISSN: 1559-3258
DOI: 10.2203/dose-response.09-019.Fornalski

THE HEALTHY WORKER EFFECT AND NUCLEAR INDUSTRY WORKERS

Krzysztof W. Fornalski 䊐 The Andrzej Sołtan Institute for Nuclear Studies, 05400 Otwock-Świerk, Poland
Ludwik Dobrzyński 䊐 The Andrzej Sołtan Institute for Nuclear Studies, 05-400
Otwock-Świerk, Poland and Faculty of Physics, University of Białystok, Lipowa 41,
15-424 Białystok, Poland
䊐 The linear no-threshold (LNT) dose-effect relationship has been consistently used by
most radiation epidemiologists to estimate cancer mortality risk. The large scattering of
data by International Agency for Research on Cancer, IARC (Vrijheid et al. 2007; TherryChef et al. 2007; Cardis et al. 2007), interpreted in accordance with LNT, has been previously demonstrated (Fornalski and Dobrzyński 2009). Using conventional and Bayesian
methods the present paper demonstrates that the standard mortality ratios (SMRs), lower
in the IARC cohort of exposed nuclear workers than in the non exposed group, should be
considered as a hormetic effect, rather than a healthy worker effect (HWE) as claimed by
the IARC group.

Keywords: nuclear industry workers, healthy worker effect, dose-response, Bayesian analysis, hormesis,
low radiation

1. INTRODUCTION

Studies of the influence of ionizing radiation on the mortality of
nuclear industry workers have been presented in several papers (Fornalski
and Dobrzyński 2009; Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et
al. 2007; Luckey 1991, 2008a; Matanoski et al. 1991, 2008; Sponsler and
Cameron 2005; Berrington et al. 2001; McGeoghegan and Binks 2000a,
2000b, 2000c; Ritz et al. 2000; Cardis et al. 1995; UNSCEAR 1994). It is well
known that very large cohorts are required to demonstrate significant
effects of low doses of radiation. Control reference groups generally need
to be at least as large or larger than the cohort of interest. The referent
group should also exhibit similar distributions of age, sex, habits, socio-economic conditions, and exposures to other confounding factors. This is
important since differences between “exposed” and “unexposed” groups
may be very small. The details of data collection and analysis are important.
Final conclusions depend heavily on the careful collection and analysis
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of data. Selection of appropriate control groups is particularly important in
studies of ionizing radiation. Perfect control groups are impossible since all
people are exposed to a potentially wide range of natural radiation (mean
2.5 mSv/year) and radiation from medical procedures (global mean 0.9
mSv/year). Natural radiation varies with location by up to three orders of
magnitude (0.7 to 700 mSv/y). People have lived at high levels of natural
radiation for millenia (Luckey 1991) in many areas of the world; for example in some districts of China (HBRRG 1981), Brasil (Guarapari) and Iran
(Ramsar). Annual doses in Ramsar can exceed 600 mSv (UNSCEAR 1994;
Luckey 2007; Luckey 2008b). High level radiation areas also exist in
Europe, e.g. in Scandinavia, France and Russia (UNSCEAR 1994, 2000).
However, no increase in mortality or decrease in longevity of people have
ever been observed in these regions. In Taiwan (Chen et al. 2004, Hwang et
al. 2008), where a group of people lived for approximately 20 years in houses contaminated by radioactive cobalt and received doses of 120 to 4000
mSv (range 6-200 mSv/y), the cancer mortality among the residents was significantly less than in the referent group. By comparison, the maximal
annual dose of 5.3 mSv in nuclear industry workers studied by
International Agency for Research on Cancer, IARC (Vrijheid et al. 2007;
Therry-Chef et al. 2007; Cardis et al. 2007) is rather small.
The relationship of cancer mortality with radiation dose received by
the exposed group is of prime importance. For example, the results from
250,000 nuclear workers was summarized by Luckey (2008b). The average mortality of nuclear workers (67 ± 13%), was substantially lower than
in control groups. A meta-analysis of mortality vs lifetime dose showed a
lower cancer mortality for nuclear workers who received lifetime doses
below 100 mSv (Luckey 2007). The control groups in Luckey’s studies
were chosen so as to minimize the Healthy Worker Effect (HWE).
Minimizing the HWE had been previously recommended (IDSP 1988;
Wen et al. 1983). The epidemiological findings of Luckey were similar to
those presented in the UNSCEAR Report (1994).
A critique of the Linear No-Threshold (LNT) hypothesis (Luckey
2007, 2000b) was supported by the nuclear shipyard worker study which
eliminated or minimized the HWE (Rockwell and Muckerheide 2008;
Sponsler and Cameron 2005). The earlier shipyard worker study
(Matanoski 1991) has recently been reanalyzed by Matanoski et al. (2008)
who now claims a small, non-significant increase in mortality for a few
cancers. A recent, case-control study of indoor radon showed a large
decrease rather than increase in lung cancer mortality (Thompson et al.
2008), similar to what had been observed in Taiwan. The HWE was not
involved in both studies. Further discussions on cancer mortality and low
dose radiation were provided by Pollycove (2009). Decreased cancer mortality was also observed in radiotherapy patients (Luckey 2008b;
Sakamoto 2004) which clearly cannot be related to the HWE.
126
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The HWE is often offered as an explanation for significantly lower
standardized mortality ratios (SMR) among nuclear workers, as well as
workers in other industries involving health risks. The HWE assumes better medical care and stricter medical requirements for nuclear workers
than for others, resulting in healthier workers. Socio-economic conditions are also important factors, in that better-educated people are
assumed to take better care of their health, and receive better nourishment. In theory, typical pre-employment health controls may contribute
to the HWE by eliminating potential cancer patients. This fact, if real,
should be reflected in a lower SMR ratio in early years of employment.
Such an effect was not observed (Figure 1) by IARC (Vrijheid et al. 2007;
Therry-Chef et al. 2007; Cardis et al. 2007). In fact the data tended to support the opposite conclusion. Dependence of the HWE on duration of
employment, as well as on the period of follow-up, has been extensively
discussed (McMichael 1976).
For interpretation of observations of a decreased mortality a quantitative approach is needed. In order to obtain a reliable description of
mortality, it is important to eliminate or minimize the HWE (Wen et al.
1983). This can be accomplished by choosing control groups with the
same or similar health levels as in study groups. The time variation of
mortality in a control population is a difficult factor in analyses. For
example, global cancer mortality has been increasing over several
decades (GUS 2007) but varying according to country. The SMR value is
lowered when mortality incidence is missed. A lower mortality is often
attributed to the HWE, even when studies involve a control cohort very
closely resembling the study cohort (McGeoghegan and Binks 2000a,
2000b, 2000c; McGeoghegan 2001; McGeoghegan 2002; Skelcher 2001;
Wen et al. 1983; Kendall et al. 1992).
The HWE can influence the study of many diseases, though its attribution of cancer rates and genetic illnesses has been questioned. Routine
pre-employment medical examinations do not eliminate cancer-susceptible individuals, as no genetic tests are carried out. “No healthy worker effect
on cancer is found” by these medical exams (Kojiro 1999). No current or
previous medical tests are able to detect signals of future cancer to eliminate cancer-prone individuals.
Dormant, subclinical malignant tumors, which are not clinically
detectable, are common in the population (Akslen and Naumov 2008;
Weinberg 2008). This is exemplified by occult thyroid cancer, the incidence of which varies from 9.0% in Poland to 35.6% in Finland (Harach
et al. 1985; Moosa and Mazzaferri 1997). Some dormant cancers can be
detected with molecular tumor markers (ACS 2009). However, such methods were not in use for pre-employment health exams at the time when
the IARC data (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al.
2007) were generated. Such methods are not included in procedures for
127
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FIGURE 1. Weighted averages of all causes SMRs as a function of the duration of employment (on
the left) and the age at death (on the right).

pre-employment health control even today, and are not recommended in
protocols of the International Commission on Radiological Protection
(ICRP). They are also not given in directives of the European Union
Council, or in International Basic Safety standards of the International
Atomic Energy Agency (IAEA).
The conclusions of several recent reviews (Luckey 2007, 2008b; Chen
et al. 2004; Hwang et al. 2008; Rockwell and Muckerheide 2008; Sponsler
and Cameron 2005; Thompson et al. 2008) are opposite from those of
IARC (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al. 2007).
Two alternative methods, a conventional least-square method and a
Bayesian approach, were used to re-analyze data compiled by IARC in
this paper.
2. IARC DATA AND THE HEALTHY WORKER EFFECT

IARC group (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al.
2007) summarized information from approximately 400,000 nuclear
industry workers from 15 countries, with analyses of all cause and all cancer mortality rates. The main results of this study (Vrijheid et al. 2007) are
presented in Figures 1 and 2. A decrease in all cause mortality in the
nuclear workers cohort is shown in Fig. 2 (data was taken from Table 7 in
(Vrijheid et al. 2007)). The standardized cancer mortality ratio was 19%
(Table 7 in Vrijheid et al. 2007). SMRs calculated as a function of worker
age and duration of employment should not be arithmetically averaged
over results coming from all 15 countries (Fornalski and Dobrzyński
128
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FIGURE 2. The SMR for all cancers (two black bars) and all causes (two grey bars) in two cases: control group of the general population and nuclear industry workers from 15 countries.

2009). A weighted average is more appropriate, because of highly variable
uncertainties in the data, with some scatterings of points extending much
further than several standard deviations. The SMR is weakly dependent
on the duration of employment (Figure 1), as opposed to the conclusions
expressed in IARC (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et
al. 2007), who attributed the data to the HWSE (Healthy Worker Survivor
Effect). It follows from Fig. 1 that collective dose is not a critical factor in
the health of nuclear industry workers. The collective dose data does not
describe spatial-temporal dose-distribution patterns, which can be of
major importance for estimating cancer risk in humans (Jaworowski
1999). Therefore, the average dose per year, rather than the collective
dose, is used in the present analysis.
The latency time for cancer formation in most cases exceeds 10 years.
Because the average follow-up time in the IARC (Vrijheid et al. 2007;
Therry-Chef et al. 2007; Cardis et al. 2007) studies was less than 13 years,
the effect of increased radiation induced cancer mortality would be
expected to be rather small or non-existent. The SMR for cancer mortality, as registered in IARC (Vrijheid et al. 2007; Therry-Chef et al. 2007;
Cardis et al. 2007), was 19%. However, the cancer mortality relative to the
all deaths in the exposed cohort was 31%. This should be compared with
a figure of about 25% which is typical for unexposed cohorts (GUS 2007).
This increased cancer death rate should not, however, necessarily be
interpreted in terms of increased cancer risk, as opposed to decreased
mortality from all other causes. The observed average mortality from all
causes, as a function of worker age (Figure 1), seems natural and is not
attributed to the influence of ionizing radiation.
129
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Cancer incidence markedly increases with increasing age. However, a
100 years of observation of British radiologists (Berrington et al. 2001)
has shown that the SMR for cancer decreases with observation time. Even
cancers with long latency periods are lower than expected from referent
groups. This effect is not connected with the Healthy Worker Effect since
“a standardized mortality ratio of 0.71 for all cancers and 0.68 for all deaths compared with other medical practitioners (who presumably also registered with professional bodies) effectively excludes a healthy worker effect in this group”; this also
indicates “a highly significant beneficial effect of radiation at moderate doses”
and implies that Berrington et al. (2001) were involved in excessive “thinking only of harmful effects of radiation”. The HWE “is used irrespective of the
extent or degree of benefit obtained within the workplace, to avoid invoking the other
scientific conclusion”, and “when we look at the entry for all cancers as a cause of
death (...) we see that our standardized mortality is a meager 0.46 (...). When this
is corrected for socioeconomic class the figure becomes 0.61, and when it is compared
with all male medical practitioners it is 0.71 (...). The authors attribute this low
death rate, at least in part, to the healthy worker effect” (Cameron and Daunt
2002). And in fact an SMR equal 1 or greater than 1 was obtained by
Berrington et al. (2001)!
There is a significant problem with the definition and calculation of
the Healthy Worker Effect (IDSP 1988; Choi 1992). The lower value of
SMR can not be shown to be connected to the HWE, when SMR values
vary by a large amount, e.g., from 40% to 110%, as found in IARC
(Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al. 2007). The
HWE depends on the cohort under study (Carpenter 1987), and, as was
also stated in the section 1, “the HWE is not a problem for cancer mortality”
because of non-existing cancer and genetic testing system at the time of
accepting people for work. The HWE has been estimated according to
the degree of the disagreement of their data with expectations in several papers. When the SMR = 90%, the HWE is said to be 10%, when SMR
= 80%, the HWE = 20%, and so on. When the results show that the SMR
= 100% or more, it is said that HWE does not appear in the study group
(Gridley et al. 1999; Meijers et al. 1989). One might then ask why one
should not assert an “unhealthy worker effect” (Brooks et al. 2007) in
such cases? SMR results differ greatly for different lines of work, material status, age and even sex (Chen and Seaton 1996; McMichael 1976). In
conclusion one must pose the difficult question of whether there is any
serious evaluation of the HWE, or whether the HWE is in effect a “Zombie
Science”, not supported by medical evidence but dogmatically used
(Charlton 2008)?
IARC study (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al.
2007) explains the reduced SMR values as due to the HWE. If this is true,
then IARC SMR results should be significantly lower than SMR values
published in earlier studies (Luckey 2008b; Wen et al. 1983; Hwang et al.
130
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2008; Sponsler and Cameron 2005; Raman et al. 1987) in which HWE was
eliminated. However, SMR values shown in IARC are larger. Therefore,
the attribution of low SMRs in IARC to HWE might be considered a
biased assumption, supported less by facts than by preconceptions. This
problem was discussed by Wagner (2003) who stated that “the healthy worker selection bias argument could go either way, depending on which way one wants
it to go”.
SMR values depend strictly on the choice of control group, and can
vary a great deal when the group characteristics vary with time. When the
hazard of interest (here the level of ionizing radiation) in the control
group is not much lower than in the studied cohort, the impact of all preconceptions on the interpretation of results can become quite high. This
can make related epidemiological studies more uncertain as sources of
information. A number of papers contain the claim that HWE should not
be invoked in epidemiological studies (Li and Sung 1999; Monson 1986;
Cohen 2002). “HWE is of little or no consequence in interpreting data on cancer
mortality” and “the healthy worker effect is relatively weak in comparison to causal
excesses that can be detected in epidemiologic data” (Li and Sung 1999).
Explanations, other than the HWE, must be considered for observed
decreases of SMR values among nuclear industry workers.
3. STANDARDIZED MORTALITY RATIO (SMR)

SMRs for all cause and all cancer mortality among nuclear workers
are presented in Fig. 3, which presents data (Vrijheid et al. 2007; TherryChef et al. 2007; Cardis et al. 2007) as a function of the annual dose
received by a person rather than the collective dose, since the collective
dose is not a good parameter for description of SMR. The error bars in
Fig. 3 reflect two standard deviations (95% confidence intervals) and are
derived from Vrijheid et al. (2007).
A very large scattering of experimental points (between 35-100%
of SMR), larger than those indicated by original error bars is seen in
Fig. 3. In addition, the data is quite inhomogeneously distributed
along the dose axis. This makes it very difficult to fit and validate any
trend line drawn from these points. In fact, this lends doubt to the
accuracy of any function fitted to these data. The most sensible solution would be to use a weighted average of data points. In order to verify this, an analysis of the simplest possible dose-effect dependences
was carried out. Two models were tested: one which treats SMR and
relative risk of contracting lethal cancer as independent of dose (in
the range of low doses received by nuclear workers), and one which
posits a linear dose-effect relationship. A similar analysis has been carried out (Fornalski and Dobrzyński 2009), in which error bars were
symmetrized, the range of studied doses somewhat limited, and the
uncertainty of the doses neglected.
131
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FIGURE 3. SMR [%] for a) deaths from all causes, b) cancer deaths vs average dose per year
[mSv/y]; the grey horizontal line is an average obtained following Bayesian analysis, the dashed line
is a Bayesian fit (“Bayes2”) and the dotted line is a standard least squares (χ2) fit. All uncertainties are
taken from IARC (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al. 2007).

3.1. Data analysis methods

Two approaches were used in the analyses: a standard statistical analysis (minimization of χ2 value) and a Bayesian analysis (Sivia 1996; Sivia
and Skilling 2006). The standard statistical approach involves evaluation
of standard deviations as an approach to characterizing the accuracy of
data. The resulting fitted regression line minimizes the function
χ 2 = ∑ ( Di − Ti )2 / σ i2 ,
i

where {Di} denote measured values, {σi} their uncertainties and {Ti}expected values calculated for parameters that are fitted to the measured
data.
In the Bayesian approach, the analysis starts with the algorithm
described by Sivia (1996) and Sivia and Skilling (2006). A primary motivation behind this approach is the assumption that estimated standard
deviations of experimental points may underestimate actual uncertainties. The plausibility for this is shown in Figure 3, given the substantial
scattering of experimental points. The Bayesian analysis is then assumed
to be sensitive to patterns through assignment of larger uncertainties to
potential ‘outliers’.
A strength of Bayesian analysis is reflected in Fig. 4. Following the
example of Sivia and Skilling (2006), a set of data containing intentional
outliers is simulated. The solid lines follow the Bayesian analysis and accurately describe the intended linear function, while the dotted lines are
direct χ2 fits; reasonable results are obtained even with outliers.
132
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FIGURE 4. Examples of Bayesian analysis fitting (solid lines) to simulated points containing intentional outliers. The dotted lines are obtained from minimizing χ2 function (least squares) – poor fit
is seen. The function f(x) shows the fitting with only 3 outliers. The g(x) contains many more outliers,
but Bayesian analysis (solid line) still works well. In the example of h(x), where the number of outliers is higher than correct data, the Bayesian approach cannot help: there are more points showing
another trend than the intended one. However, when number of outliers is high and they lie above
and below the main trend, the Bayesian analysis still works (see j(x)).

The Bayesian analysis begins with the probability of observing an
experimental value E when T is expected,

(

)

P E σ ,o =

1
2πσ

exp {−(T − E )2 / (2σ 2 )} p(σ ),

(1)

where p(σ) is a probability of uncertainty σ in the experimental data E.
The parameter o stems from other parameters representing the problem.
When this is unknown, the so-called Jeffrey’s prior (Sivia and Skilling
2006) defines:
p(σ ) =

1
1
⋅
ln(σ max / σ min ) σ

(2)
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where σmax and σmin are the upper and lower limits of uncertainty σ. Such
values can be difficult to assign, and one can also use another prior (Sivia
and Skilling 2006),
p(σ ) =

σ0
σ2

(3)

where σ0 is an uncertainty assigned to the given point E. Given a set
{Ei,Ti}, with, for example, Ti = aDi + b, (with a and b fitting parameters),
the logarithm of the total probability of data {Ei} is:
N

N

i =1

i =1

L = ∑ ln Li =∑ ln

1

∫

2πσ i

exp {−(Ti − Ei )2 / (2σ i 2 )} p(σ i )dσ i

(4)

Parameters a and b are obtained from maximizing (4), i.e., setting
dP/da and dP/db to zero:
N

dTi

N

dTi

∑ g (T − E ) dα ≡ ∑ g R dα
i

i

i

i =1

i

n

i =1

i

=0

(5)

n

where the weights gi depend on residuals Ri = Ti – Ei, with {Ti} functions
of n = 1, .., Np parameters. For example, with the prior (3) the weights
are:
gi =

⎪⎫
Ri2
1 ⎧⎪
1
⋅
2
−
⋅
⎨
⎬
2
2
2
2
Ri ⎪⎩ σ 0 i exp( Ri / 2σ 0 i ) − 1 ⎭⎪

(6)

Solving (5) numerically yields a and b. Finally, the Hessian is calculated to estimate uncertainty of the parameters. More detailed information
is given in Fornalski and Dobrzyński (2009).
A Bayesian statistical approach to model selection is discussed in Sivia
and Skilling (2006). Here it is necessary to find the posterior ratio of two
likelihood functions of the candidate models, say A and B:
posterior _ ratio =

prob( A | D, I )
prob( B | D, I )

(7)

where D denotes original data and I the knowledge from the preexperimental information. The posterior probabilities for A and B are
then products of probabilities for all data points. Using Bayes’ theorem:
prob( A | D, I ) = prob( D | A, I ) × prob( A | I ) / prob( D | I )
prob( B | D, I ) = prob( D | B, I ) × prob( B | I ) / prob( D | I )

(8)

The terms prob(A|I) and prob(B|I) cancel when neither A nor B is preferred initially. The terms prob(D|I) are set in both equations to the same
constant value. For a model B with an adjustable parameter λ, the term
prob(D|B,I) are expressed as:
prob( D | B, I ) =

∫ prob( D | λ , B, I ) × prob(λ | B, I )d λ

(9)
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The value prob(D|λ,B,I), where λ is given, is a standard likelihood function. When λ is assumed to lie between λmin and λmax, a prior within this
range is written as:
prob(λ | B, I ) =

1
for λmin ≤ λ ≤ λmax
λmax − λmin

(10)

Let λ0 denote the value of λ which yields the closest agreement with
the measurements, so the probability prob(D|λ0,B,I) maximizes B’s likelihood function. This is represented using a Gaussian function:
⎛ (λ − λ ) 2 ⎞
0
prob( D | λ , B, I ) = prob( D | λ0 , B, I ) × exp ⎜⎜−
⎟
2δλ 2 ⎟⎠
⎝

(11)

We can calculate (9) using both (10) and (11). Putting the result into
(8) yields the final form of (7):
λ − λmin
prob( A | D, I ) prob( A | I )
prob( D | A, I )
× max
=
×
prob( B | D, I ) prob( B | I ) prob( D | λ0 , B, I )
δλ 2π

(12)

The first term on the right reflects relative prior preference for alternative theories. As stated earlier, these probabilities can be the same, so
that the first term is 1. The second term involves the primary estimation
of the models’ agreement with data. The last term is a so called
“Ockham’s factor”, preventing use of over-complicated models (Sivia and
Skilling 2006).
3.2 Fitting linear dose-effect relations to SMR

Two independent models were tested in order to describe SMR data.
The first (denoted as M1) assumes that the standardized mortality ratio
(SMR) is independent of annual dose, so that the fitted function is y =
const. The second model (M2) assumes SMR = a<D> + b, where <D> is the
average annual dose. A priori it is difficult to decide between M1 or M2,
so both models are assigned the same probability of acceptance. The analyzed data are contained in Tables 5 and 7 in (Vrijheid et al. 2007).
Implementation of model M1 involves calculation of standard
weighted averages. The uncertainties are presented originally in terms of
two standard deviations. In the case of SMR for all cause mortality, one
obtains SMR = (67.8 ± 14.7)% with χ2 = 226.5, and in the case of SMR for
all cancer mortality, one obtains SMR = (76.5 ± 13.0)% with χ2 = 18.7.
The values of χ2 and large uncertainties show that the deviations of
points from their averages are much larger than claimed uncertainties
permit. One might conclude that M2 better describes the data. The two
parameters were obtained by least-squares; parameters obtained for the
M2 model are shown in Table 1. The SMRs are shown as functions of
annual doses. Cumulative doses are found in Table 1 for comparison
with other studies.
135
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TABLE 1. Parameters of straight lines fitteda to the SMR data presented in Tables 5 and 7 of IARCb
(Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al. 2007).
Subject of SMR

a

b

χ2

All causes vs cumulative average dosec
All causes vs average annual dosec
All causes vs average annual dosed
Cancers vs cumulative average dosec
Cancers vs average annual dosec
Cancers vs average annual dosed

-0.26 ± 0.06
-2.34 ± 0.62
- 0.11 ± 0.41
0.35 ± 0.13
4.75 ± 1.39
5.35 ± 0.92

0.727 ± 0.013
0.719 ± 0.012
0.706 ± 0.009
0.701 ± 0.026
0.685 ± 0.025
0.682 ± 0.018

888.7
891.7
193.1
68.2
63.2
13.7

a

A standard least-squares fit was used.
All doses are given in mSv.
c
Symmetric uncertainties (one standard deviation).
d
Original asymmetric uncertainties from the IARC papers (Vrijheid et al., 2007; Therry-Chef et al.,
2007; Cardis et al., 2007), see Fig. 3 (thin lines). Note that these uncertainties are twice as high as the
standard deviations. Therefore χ2 is lower by the factor of 4 with respect to that calculated when single standard deviations are used.
b

The analysis shows (also reflected in Table 1) that parameter b is well
defined, and is close to 0.70 (i.e. the SMR is at a level of 70%). A different
conclusion is appropriate for the slope parameter a. Its value is strongly
dependent on how calculations are carried out (in fact its sign also depends
on this). This is a consequence of the scattering of points. The high values
of χ2 show that model M2 cannot be treated as an improvement over model
M1. Although the values of χ2 are smaller for M2, one should note that M2
contains a larger number of fitted parameters than M1. The lower χ2 values
consistently follow from larger uncertainties in the data on cancer mortality, and the larger uncertainties result from much lower statistics (smaller
data sets). The reliability of these data is not high.
The negative and positive values of slope parameter, a, may cause
some confusion. It would be expected that better understanding of the
data follows from Bayesian analysis, where all uncertainties can be treated as dubious and usually underestimated. The calculations are given in
section 3.1.
In the Bayesian analysis of SMR data, both above-mentioned priors, the
Jeffrey’s prior [∝1/σ] (2) and the alternative prior [∝1/σ 2] (3), were used.
The results for the latter are described as “Bayes2”. The results obtained for
the model M1 are presented in Table 2 for both cases: all cause mortality
and all cancer mortality. The results, SMR = (73.3 ± 1.3)% for all cause mortality, and SMR = (76.1 ± 6.5)% for all cancer mortality, obtained with prior
(3), appear stable and are reasonably based on results presented in Figures
1-3. Taking original asymmetric uncertainties from (Vrijheid et al. 2007;
Therry-Chef et al. 2007; Cardis et al. 2007), one obtains an SMR for all cause
mortality of 73.7 ± 0.8 % and an SMR for all cancer mortality of 78.3 ± 3.8
%. These values are found in Fig. 3 as horizontal lines.
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TABLE 2. SMR results of the Bayesian analysis for model M1 with Jeffrey’s prior and the Bayes2 priora. In the case of the Jeffrey’s prior, the values of constant SMR were calculated by allowing the
declared uncertainties to be raised by the multiplicative factor, mult, which is shown in the 2d column.
Subject

Mult

Constant

χ2

SMR all causes vs cumulative average dose [mSv]

1.1
5.0
20.0
100.0
Bayes2
1.1
5.0
20.0
100.0
Bayes2

0.677 ± 0.005
0.694 ± 0.016
0.730 ± 0.019
0.734 ± 0.016
0.733 ± 0.013
0.765 ± 0.009
0.764 ± 0.037
0.755 ± 0.011
0.743 ± 0.070
0.761 ± 0.065

768.0
60.0
20.8
15.8
29.2
67.6
17.1
12.1
10.9
20.1

SMR cancers vs cumulative average dose [mSv]

a

Symmetric uncertainties and one standard deviation were taken into account

Using the Jeffrey’s prior in (2) of section 3.1 requires using the factor
mult, which gives a range of uncertainties from σmin = σo to σmax = mult ·
σo. The symbol σo denotes initial uncertainty. Table 2 contains results for
different mult. Going beyond mult = 20 is not necessary, since the expected value of χ2 for this factor is about 19, which equals the number of data
points. This value of mult is relatively high and indicates that the uncertainties in data from different sources are greatly underestimated. A possible alternative explanation of these data is that they can be treated as
independent, so that no common function would apply to them.
The values of SMR in Table 2 are close to those obtained previously
by weighted averaging. However, differences in the uncertainties show
that the Bayesian method can improve on conventional least-squares.
Fitting an SMR which is independent of dose appears to give reasonable results. However, for completeness and comparison with Table 1, linear models (model M2) were fitted to the same data. The line parameters
obtained with the Jeffrey’s prior and various multiplication factors are
shown in Table 3. Table 4 presents results obtained with the second prior
TABLE 3. SMR for all causes vs the cumulative average as obtained for various multiplication factors in the Bayesian analysis using Jeffrey’s prior – model M2 (with symmetric uncertainties and
one standard deviation).
Mult.

a

b

χ2

1.1
5.0
20.0
100.0

-0.25 ± 0.07
-0.04 ± 0.21
0.27 ± 0.17
0.27 ± 0.18

0.725 ± 0.014
0.699 ± 0.034
0.674 ± 0.036
0.673 ± 0.037

753.9
59.4
19.7
14.9
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TABLE 4. Parameters of the linear dose-effect dependence of SMR obtained within the Bayes2
approach – model M2 (with symmetric uncertainties and one standard deviation)a.
Subject (SMR)

a

b

χ2

All causes vs average cumulative dose
All causes vs average annual dose
Cancers vs average cumulative dose
Cancers vs average annual dose

0.28 ± 0.15
4.31 ± 1.81
0.55 ± 0.24
6.51 ± 2.59

0.672 ± 0.031
0.651 ± 0.035
0.671 ± 0.043
0.662 ± 0.042

27.6
25.8
16.4
16.1

a

All doses [in mSv] are individual cumulative ones.

(proportional to 1/σ2 – the “Bayes2”). The latter are very similar to those
obtained with the Jeffrey’s prior and mult at 20 or more.
Two significant observations are implied by Tables 3 and 4:
• a negative slope, a, for all cause mortality when the mult for Jeffrey’s
prior is small. This indicates acceptance of uncertainties as originally
given. This trend changes when mult increases and approaches the results of the ‘Bayes2’ model. The change in slope is the result of the extensive scattering of data points.
• The second observation relates to cancer mortality. The slope, a, is
consistently positive, since the related data exhibit less scattering. In
addition, the fitted lines are only weakly dependent on the way the
data are analyzed.
The results in Tables 3 and 4 were obtained using symmetric uncertainties (one standard deviation). Assuming initially asymmetric uncertainties (two standard deviations) from the IARC data (Vrijheid et al. 2007;
Therry-Chef et al. 2007; Cardis et al. 2007), the results do not significantly
change. An SMR = (4.44 ± 0.93) <D> + (64.9 ± 2.2) [%] was obtained for
all cause mortality, and an SMR = (6.77 ± 1.46) <D> + (66.2 ± 2.7) [%] for
all cancer mortality. Here <D> is the average annual dose (in mSv)
received by one person. The related graphs are shown in Fig. 3. For <D> =
0, the SMR values for all cancer and for all cause mortality are very similar, but the increase with dose is about 1.5 times higher for all cancers.
Assuming a non-zero slope, the SMR for deaths from all cause and for
all cancer mortality increases with dose (Table 4 and Figure 3). However,
the starting level of SMR is more than ~30% below normal. The parameters
obtained in Table 4 are very close to those obtained by using the Jeffrey’s
prior and mult values above 20 (Table 3). Note, however, that two data
points corresponding to the highest doses generally lie below the straight
lines of Fig. 3. This is contrary to what would be expected: the highest slope
is obtained from the data at lowest doses. Thus, in spite of the consistency
of the results of fits, the estimated slopes cannot reflect actual values. This
supports the conclusion that model M1 is more reliable than M2.
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There are two other factors which favor model M1 over M2. The first
is the fact that the increase of SMR with dose (Table 4) is rapid; for example the slope for cancer in annual doses is 6.5. With this information and
a standard interpretation of cumulative dose, one would expect that after
10 years of exposure one would have SMR=130%, and after 20 an
SMR=200%. This in fact would be for an annual dose of only 1 mSv! This
type of mortality increase is implausible and has not been seen. This
would imply that model M2 cannot be fully correct, since it predicts
implausibly high mortalities.
The second factor involves a more mathematical analysis: through a
Bayesian approach, one finds that model M1 for all causes of death is two
times more likely than M2. This is obtained from dividing two likelihood
functions for all input points by a factor containing parameter ranges
(the Ockham factor) – see “model selection” in Sivia and Skilling (2006)
and section 3.1.
4. RELATIVE RISK (RR) OF CANCER DEATH

In the paper of Cardis et al. (2007), the authors present data based on
relative mortality ratios, taking workers with lowest doses as a control
group. Thus, for the least exposed group, RR was taken as RR=1, with
some resulting internal comparisons (Fig. 5). An alternative statistical
analysis of these data is presented below. As before, two models (section
3.2): M1, with constant and dose-independent relative risk RR, and M2,
with relation RR = a<D> + b were tested, where <D> is the cumulative
dose. Two analysis methods were used: classical least-square fit (minimum
χ2) and Bayesian analysis (see section 3.1).
It follows from Table 1 in (Cardis et al. 2007) (which contains all the
required data), that an increase of RR for leukemia is observed at a cumulative dose as low as 7.5 mSv (Fig. 6). In light of these extensive data,
including the data from Hiroshima and Nagasaki (UNSCEAR 1994, 2000),
such an increase is not plausible. In addition, this increase, though not
very pronounced, occurs also for all causes of death, all cancers, solid cancers, non-cancer causes and many other results. Although hypersensitivity
was observed in some colonies of cells in these cases, one cannot expect
that this may describe a large population of people. There are in fact at
least two ways to explain this phenomenon: one involves systematic errors
in data collection. To correct the data in this case, one would need to
adjust all of the data points downward, resulting in the value RR=1 at this
local maximum, for a dose of 7.5 mSv. The second potential explanation
is an unknown cause of deaths, not connected with ionizing radiation.
Two other questions occur when one inspects the data for higher
cumulative doses. The first involves the unusually high relative risk
obtained for a dose of 175 mSv. For example, considering mortality from
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FIGURE 5. Relative Risk (RR) vs cumulative dose [mSv] from all cancers deaths. Solid horizontal line
corresponds to RR=1, the highest dashed line is a fit as given by IARC (Vrijheid et al. 2007; TherryChef et al. 2007; Cardis et al. 2007), grey solid line corresponds to the least-squares solution, and dotted line is a Bayesian fit, when the point for 175 mSv is not taken into account.

FIGURE 6. The Relative Risk (RR) connected with the cumulative dose for a) the leukemias without
CLL, and b) all cancers without leukemias. The local maximum for the 7.5 mSv is clearly seen in both
cases.

all cancers (Fig. 5), this data point appears too large. It might be reasonable to consider this point an ‘outlier’ and, for the moment, neglect it in
this part of analysis. The second question involves data above a level of 500
mSv. In this dose range a very small number of deaths is registered, and it
is unclear how much weight should be given to this data point, in particular since the dose uncertainty here appears high. Therefore the analysis has
been carried out both with and without this point taken into account.
Results of all least-square and Bayesian analyses are shown in Table 5.
The data are divided into three groups depending on the number of
points. The first shows the results obtained when all 11 points published
in (Cardis et al. 2007) are included. The next column contains the result
140
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TABLE 5. Results of Relative Risk (RR) based on least-square and Bayesian analysisa.
Results
Subject

All 11 points

Below 500 mSv

without point at 175 mSv

Model M1,
least-square method
Model M2,
least-square method

x

<RR> = 1.001 ± 0.004

a = (3.4 ± 5.1)·10-4
b = 0.990 ± 0.024

a = (3.1 ± 4.2)·10-4
b = 0.991 ± 0.022

Modifiedc model M2,
least-square method
Model M2,
Bayesian method
(‘Bayes2’)

a = (2.74 ± 2.93)·10-4

a = (2.43 ± 3.17)·10-4

a = (3.0 ± 18.1)·10-4
b = 0.99 ± 0.25

a = (2.4 ± 16.7) ·10-4
b = 0.99 ± 0.24

<RR> = 0.994 ± 0.005
–b
a = (1.6 ± 2.4)·10-4
b = 0.991 ± 0.008
a = (1.2 ± 4.5)·10-4
b = 0.992 ± 0.022
–b
a = (0.58 ± 2.17)·10-4
–b
a = (2.1 ± 3.2)·10-4
b = 0.99 ± 0.07

a

The data were divided into three groups, depending on the number of analyzed points.
Only 9 points: the 175 mSv and above 500 mSv ones were excluded.
c
Where b=1; function y = ax + 1 was fitted to the data.
b

of the analysis using the 10 points below 500 mSv. The last column shows
the results when only 9 points are taken into account, with the point at
175 mSv considered an ‘outlier’.
It follows from Table 5 that, after removing the point for dose range
above 500 mSv, the value of RR, obtained by least-squares applied to
model M1, is <RR> = 1.001 ± 0.004, with χ2= 11.2. If, in addition, the point
at 175 mSv is removed as an outlier, <RR> changes to 0.994 ± 0.005 with
χ2= 2.1. The large drop in χ2 shows that all the poor fits in the previous
value <RR> are due to this single point. It is important to note that the
remaining points lie almost exactly on the line RR = 1 (this is similar to
the problem mentioned earlier, where the value of RR for leukemia at the
low dose of 7.5 mSv appears overestimated).
A great increase of RR is consistently found at 175 mSv in all cause
mortality, lung cancer deaths, solid cancer deaths, and all cause mortality, excluding leukemia. Generally speaking, the trends (shown in Fig. 6)
of RR among all cause mortality, all cancer mortality or cancer deaths,
excluding leukemia, are quite similar.
When model M2 is used, the uncertainty in slope (one standard deviation) is approximately the size of the slope itself. Although this does not
invalidate the model in itself, it does indicates that the model might have
lower credibility. Moreover, using model M2 consistently yields values of b
lower than 1. Because of the basic assumption that RR at the lowest dose
must be one, the function RR = a·x + 1 has also been fitted to the data.
Results of these fits are also included in Table 5, though they are not significantly different from previous ones.
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One more observation should be noted regarding the M2 model:
results in Table 5 show again that the one point at 175 mSv is the main
cause of all the uncertainty in the value of the slope, a. It is important that
when this point is not included, the χ2 values for the M2 model are not
much better than ones for model M1. Thus, use of the additional slope
parameter, a, does not enhance information on the dose-effect relationship (Sivia and Skilling 2006). The lines given originally by IARC (Cardis
et al. 2007) are shown in Figure 5.
When the Bayesian approach is used, χ2 values decrease as expected;
however, this is accompanied by an increase in standard deviations of a
and b. This can be expected, since achieving a more representative result
(dataset) requires effective increases in data uncertainties. A consequence of this is that for IARC data, the Bayesian approach is less helpful
in assigning a dose-effect dependence for RR.
In the above calculations the uncertainties in doses (whose estimates
are given by horizontal error bars in Fig. 5) were neglected. When taken
into account, the value of the slope parameter decreases by about 1%
when all data are included, but as much as by 14% when the data for 175
mSv are excluded.
Thus, we can conclude that the RR data (Cardis et al. 2007) does not
require an M2 model with non-zero slope. The simpler model of the two,
which give similar results is preferred (according to Ockham’s razor, Non
sunt multiplicanda entia sine necessitate). In the present case, this is the M1
model, where RR = const.
5. CONCLUSIONS

The analysis of data published in IARC (Vrijheid et al. 2007; TherryChef et al. 2007; Cardis et al. 2007) on the mortality of nuclear industry
workers from 15 countries indicate both a decrease in the SMR and an
approximate dose-independence of relative risk (RR) for cancer mortality for the range of doses evaluated (Figs 2 and 5). This has frequently
been observed in a number of other health studies of nuclear industry
workers over the world. Using two alternative statistical methods – the
standard least-square test and a Bayesian analysis (Sivia 1996; Sivia and
Skilling 2006) – both SMR and RR data have been shown as either independent of dose or having a linear dose-effect relationship known as the
LNT. Although the IARC data (Vrijheid et al. 2007; Therry-Chef et al.
2007; Cardis et al. 2007) do not negate the possibility of LNT-type dependence, the present analysis indicates that it is much more likely that no
dependence on dose exists. An attempt to see the agreement of the data
with the LNT hypothesis might be considered more a matter of prior
belief than reasoning based on the data (Oakley et al. 2006).
There are few statistically backed facts which would justify the belief
that doses received by the studied cohort of workers could be a cause of
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cancer mortality. The average annual doses received by the workers in
these studies were at a level of 2 mSv, and even in the more extreme case
of Switzerland, they did not exceed 5.3 mSv/year. These doses are comparable with average global natural radiation levels, which are about 2.4
mSv, and are much lower than in the study of radiologically contaminated houses in Taiwan (Chen et al. 2004; Hwang et al. 2008), or in some
areas of China (HBRRG 1981), and a number of other countries
(UNSCEAR 2000). The data presented by Luckey (2007, 2008b),
Thompson et al. (2008) and UNSCEAR (1994) are quite similar to those
of IARC (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al. 2007)
(Figs 1 and 2) and consistently show substantial decreases of cancer mortality as compared with “unexposed” reference cohorts. There is little reason to believe in an HWSE in the IARC cohort (Fig. 2) (Arrighi and
Hertz-Picciotto 1994).
The IARC authors (Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis
et al. 2007) do not consider the possibility that the effects of radiation
exposure could be beneficial (Fig. 2) (Luckey 2008b). The potentially
therapeutic role of low doses of ionizing radiation is supported by biological arguments and facts (Nowosielska et al. 2009; Cohen 2008; Lin
2007; Pollycove 2007; Sakamoto 2004; Hosoi and Sakamoto 1993), in particular using the microdose and adaptive response models (Leonard
2008; Scott et al. 2009). To the potential detriment of the study, such facts
and possible interpretations were not considered by IARC group
(Vrijheid et al. 2007; Therry-Chef et al. 2007; Cardis et al. 2007).
The HWE was used by IARC (Vrijheid et al. 2007; Therry-Chef et al.
2007; Cardis et al. 2007) as the only explanation of lower than expected
mortality; the view is not supported by published data. In fact, there are
many who believe that the HWE should not be used in analysis of cancer
and in epidemiological studies (Li and Sung 1999; Monson 1986; Cohen
2002; Kojiro 1999; Cameron and Daunt 2002; Carpenter 1987; Sanders
2008). The most prominent deficit in the IARC data is the extremely high
data variance. The focus should be on cause of observed differences in
SMRs if the HWE were indeed responsible. To learn why SMR levels varied so widely it would be of interest to compare the pre-employment and
employment medical routines to which workers were subjected in the 15
countries. This type of study could shed more light on the HWE problem.
On the other hand, the analysis of the IARC data (Vrijheid et al. 2007;
Therry-Chef et al. 2007; Cardis et al. 2007) treats all reported values of
SMR using the same underlying model. The above re-analysis of these
data shows primarily that the results of the analysis depend heavily on the
way it is carried out. As mentioned before, the SMR data are inconclusive
due to the large scattering of points and uneven distribution along the
dose axis, while the very sparse RR data may contain at least one outlier.
In spite of the strength of the Bayesian method, the present paper shows
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that in the case of such inconsistent data there is no reason to use strong
mathematical tools, and that a “common sense” approach in such situations can be sufficient. The implication most consistent with the IARC
data is that neither SMR nor RR is dependent on dose, while the most
solid conclusion concerns their average values.
A review of the data published by IARC and re-analyzed by Fornalski
and Dobrzyński (2009) reveals inadequate statistics on all cause and all
cancer mortality. It is also very important to examine and analyze morbidity, and not only mortality, in the same cohort of workers.
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Fornalski K. W. and Dobrzyński L. 2009. Ionizing radiation and health of nuclear industry workers,
Int. J. of Low Radiation, vol. 6, no 1, pp. 57-78
Gridley G., Nyren O, Dosemeci M, Moradi T, Adami HO, Carroll L, Zahm SH, 1999. Is there a healthy
worker effect for cancer incidence among women in Sweden?, Am. J. of Industrial Med. 36: 193199
GUS. 2007. Główny Urza˛d Statystyczny, Ochrona środowiska, Warszawa, p. 416-417
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